ENTER

ENTER

ENTER is the fastest, most accurate, and most transparent Revenue Cycle Management Platform in healthcare powered by AI.

Founded 2013 20 employees Seed Total: $11.33M Digital Health, Finance +5

Enter, Inc. is a cutting-edge Revenue Cycle Management (RCM) platform in the healthcare industry. Equipped with artificial intelligence, it boasts being the fastest, most accurate, and transparent solution. Founded in 2013, it has garnered substantial attention and recently received a noteworthy $5.70M in a Seed Round investment on 08 March 2022. Enter's innovative approach aims to revolutionize the RCM landscape by enhancing Payer reimbursements by 10%, mitigating HIPAA risk, and fostering patient satisfaction. It strives to alleviate the burden faced by Providers by offering unparalleled operational efficiency, automation, transparency, and compliance. With its Claim A.I., Enter has demonstrated the potential to escalate reimbursements by 15%-40% and expedite the processing speed by up to 50%. Additionally, its Patient A.I. contributes to a 10% improvement in patient collections. The company's solution helps businesses recover funds faster and more cost-effectively, thereby negating the need for additional resources or compromising customer relationships. Enter's commitment to transparent pricing, devoid of any upfront costs, augurs well for its long-term success. With the daunting statistics of over $150B annually going to collections and 77M Americans having bills in collections, Enter endeavors to prevent consumers from falling into the collections trap by assisting businesses in capturing a larger portion of their revenue intelligently. The recent Seed Round investment of $5.70M was propelled by a consortium of prominent investors including Valia Ventures, 500 Startups, Menlo Ventures, Quiet Capital, SpringRock Ventures, Umami Capital, Savantus Ventures, and Matt Roszak. This injection of capital is poised to facilitate the further expansion and innovation of Enter's RCM platform, positioning it as a prominent player in the burgeoning healthcare technology sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	$5.70M	8	Valia Ventures, 500 Startups +6	08 Mar 2022
Seed Round	Undisclosed	1	500 Startups	20 Oct 2021
Seed Round	$5.50M	1	Quiet Capital	30 Jan 2019
Seed Round	Undisclosed	2	500 Startups, AltaIR Capital	24 Jul 2018
Seed Round	$125.00K	3	500 Startups, AltaIR Capital +1	23 Dec 2015
Seed Round	Undisclosed	2	AltaIR Capital, Hard Yaka	23 Sep 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

$5.70M

Valia Ventures, 500 Startups +6

08 Mar 2022

Seed Round

Undisclosed

500 Startups

20 Oct 2021

Seed Round

$5.50M

Quiet Capital

30 Jan 2019

Seed Round

Undisclosed

500 Startups, AltaIR Capital

24 Jul 2018

Seed Round

$125.00K

500 Startups, AltaIR Capital +1

23 Dec 2015

Seed Round

Undisclosed

AltaIR Capital, Hard Yaka

23 Sep 2015

FAQ About ENTER

ENTER is the fastest, most accurate, and most transparent Revenue Cycle Management Platform in healthcare powered by AI.

ENTER was founded in 2013.

ENTER operates in Digital Health, Finance, Financial Services, Fintech, Health Care, Payments and Health insurance. Its work centres on Revenue Cycle Management, Medical Billing, Healthcare Payments and Financial Technology.

ENTER has approximately 20 employees.

ENTER has completed 6 funding rounds, raising a total of $11.33M. The latest funding stage is Seed.

Top alternatives and competitors to ENTER include Cedar, Millennia, Medical Business Bureau, Waystar, The Patriot Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ENTER and Cedar are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About ENTER

Funding Rounds & Investors (6)

ENTER Alternatives & Competitors

FAQ About ENTER